Use of cholinesterase inhibitors in dementia

Advances in Psychiatric Treatment

Volumn 8, Issue 2, 2002, Pages 89-96

  Holden, Mark ^a   Kelly, Cornelius ^a  

^a HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; METRIFONATE; MILAMELINE; PHOSPHATIDYLSERINE; PHYSOSTIGMINE; PLACEBO; RIVASTIGMINE; SABCOMELINE; TACRINE; XANOMELINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; DRUG ABSORPTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG RESPONSE; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MUSCLE WEAKNESS; PHOTON EMISSION TOMOGRAPHY; PRESCRIPTION; QUALITY OF LIFE; TREATMENT INDICATION; VASCULAR DISEASE;

EID: 0036200062     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.8.2.89     Document Type: Article

References (27)

1. The clock-drawing test
2. Anti-dementia drugs
3. Alzheimer's disease: Genotypes, phenotypes and treatments
4. A randomised trial evaluating the efficacy and safety of rivastigmine in patients with mild to moderately severe Alzheimer's disease
5. The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia
6. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician
7. The Bayer Activities of Daily Living Scale (B-ADL)
8. A 30 week randomised control trial of high dose tacrine in patients with Alzheimer's disease
9. The Clinician Interview-Based Impression (CIBI)
10. Metrifonate
11. Tacrine efficacy in Lewy body dementia
12. Guidelines on drug treatment for Alzheimer's disease
13. Efficacy of rivastigmine in dementia with Lewy bodies. A randomised, double-blind, placebo-controlled international study
14. Donepezil in Alzheimer's disease: Eighteen month results from the Southampton Memory Clinic
15. Cognitive impairment in elderly people: Population based estimate of the future in England, Scotland and Wales
16. Effects of Metrifonate on the cognitive, global and behavioral function of Alzheimer's disease patients: Results of a randomised double-blind placebo controlled study
17. Guidance on the use of donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease
18. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
19. A 24 week double-blind placebo controlled trial of donepezil in patients with Alzheimer's disease
20. A new rating scale for Alzheimer's disease
21. Eligibility of Alzheimer's disease clinic patients for clinical trials
22. Galantamine - A review of its use in Alzheimer's disease
23. Burden: A review of measures used among care givers of individuals with dementia
24. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain